Sahar Bedrood, MD, PhD

Sahar Bedrood, MD, PhD

Sahar Bedrood, MD, PhD, is a glaucoma and cataract specialist at Advanced Vision Care in Los Angeles, California. She received her undergraduate degree in biochemistry and chemistry at University of California Los Angeles. She then completed a combined MD/PhD program at the Keck School of Medicine of USC. She received her PhD in biochemistry and molecular biology for her work on structural features and drug modifiers of misfolded proteins such as amyloid proteins involved in neurodegenerative diseases and diabetes mellitus.

She finished her residency in ophthalmology at the Doheny/USC Roski Eye Institute in Los Angeles, CA. She then completed her fellowship in glaucoma as a Society of Heed Fellow at the Wilmer Eye Institute at Johns Hopkins University in Baltimore. Additionally, Dr. Bedrood has been honored with multiple awards throughout her training for both her leadership and her research endeavors.

Dr. Bedrood is an invited speaker at multiple national conferences on the topic of glaucoma and glaucoma surgery. She is on the editorial board for Glaucoma Today as well as the American Academy of Ophthalmology's EyeNet publication. She also serves on the Board for Women in Ophthalmology. She currently is in private practice at Advanced Vision Care in Los Angeles, CA as well as Clinical Assistant Professor at USC Roski Eye Institute and Los Angeles County Medical Center where she teaches ophthalmic surgical training to the residents.

2

Resources
Practical Experience With iStent infinite® From a Comprehensive Ophthalmologist
Surgery
Practical Experience With iStent infinite® From a Comprehensive Ophthalmologist

Join Sahar Bedrood, MD, PhD, and Deborah Gess Ristvedt, DO, for ergonomic pearls for the iStent infinite.®


January 9, 2024
Managing Glaucoma in the Year 2030
Clinical Guides
Managing Glaucoma in the Year 2030

In this session from Eyes on Glaucoma 2022, Sahar Bedrood, MD, PhD, examines the changing landscape of glaucoma management, including drug delivery, remote monitoring, and the role of artificial intelligence.

August 31, 2022